45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
○Discounted cash price: below assessment threshold
●Payer-specific negotiated rates: assessment threshold met
●Min / max negotiated charges: assessment threshold met
●Free, public, no login required: assessment threshold met
Procedures listed
15,088
Insurances with rates
16
CPT / HCPCS codes
11,703
Most expensive procedures (gross)
J0225
$227,361
VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE
Gross
$744,578
J0225
$227,361
VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE
Gross
$744,578
J1303
$121,994
RAVULIZUMAB-CWVZ 10 MG/ML INTRAVENOUS SOLUTION
Gross
$399,514
J1303
$121,994
RAVULIZUMAB-CWVZ 10 MG/ML INTRAVENOUS SOLUTION
Gross
$399,514
90378
$89,494
PALIVIZUMAB 100 MG/ML INTRAMUSCULAR SOLUTION
Gross
$293,083
90378
$89,494
PALIVIZUMAB 100 MG/ML INTRAMUSCULAR SOLUTION
Gross
$293,083
J0285
$88,576
AMPHOTERICIN B 0.1 MG/ML IV SYRINGE (NEONATE)
Gross
$290,074
J0285
$88,576
AMPHOTERICIN B 0.1 MG/ML IV SYRINGE (NEONATE)
Gross
$290,074
C1877
$75,865
THRAFLX HBRD ANTFLO 30X40X150A THA3040X150A
Gross
$248,448
C1877
$75,865
THRAFLX HBRD ANTFLO 30X40X150A THA3040X150A
Gross
$248,448
C1882
$57,216
ACTICOR 7 HF-T 429523
Gross
$187,374
C1882
$57,216
ACTICOR 7 HF-T 429523
Gross
$187,374
J2020
$54,019
LINEZOLID 2 MG/ML IV SYRINGE (NEONATE)
Gross
$176,905
J2020
$54,019
LINEZOLID 2 MG/ML IV SYRINGE (NEONATE)
Gross
$176,905
C1605
$52,022
PACER SYS AVEIR DUAL CHAMBER DR-SYSTEM-AVEIR
Gross
$170,364
C1605
$52,022
PACER SYS AVEIR DUAL CHAMBER DR-SYSTEM-AVEIR
Gross
$170,364
C1824
$49,854
OPTIMIZER SMART IPG 10-B411-3-XX
Gross
$163,266
C1824
$49,854
OPTIMIZER SMART IPG 10-B411-3-XX
Gross
$163,266
J1747
$49,678
SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION
Gross
$162,690
J1747
$49,678
SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION
Gross
$162,690
C1820
$47,686
KT IMP VERCISE GEVIA GENRTR M365DB1200S0
Gross
$156,167
C1820
$47,686
KT IMP VERCISE GEVIA GENRTR M365DB1200S0
Gross
$156,167
C1826
$47,686
NEUROSTIMULATOR RECHRG 977119
Gross
$156,167
C1826
$47,686
NEUROSTIMULATOR RECHRG 977119
Gross
$156,167
J9266
$47,528
PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION
Gross
$155,647
J9266
$47,528
PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION
Gross
$155,647
C1767
$46,700
DRG IPG PROCLAIM W/CONTROLLER 3664CTRLSYSXX
Gross
$152,937
C1767
$46,700
DRG IPG PROCLAIM W/CONTROLLER 3664CTRLSYSXX
Gross
$152,937
C2624
$45,519
SYS DEL PA SENS CARDIOMEMS CM2000
Gross
$149,069
C2624
$45,519
SYS DEL PA SENS CARDIOMEMS CM2000
Gross
$149,069
J9228
$44,879
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$146,973
J9228
$44,879
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$146,973
J9359
$44,767
LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION
Gross
$146,606
J9359
$44,767
LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION
Gross
$146,606
J0222
$43,072
PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION
Gross
$141,054
J0222
$43,072
PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION
Gross
$141,054
C2616
$38,474
THERASPHERE Y-90 1-20GBQ Y90THERA
Gross
$125,998
C2616
$38,474
THERASPHERE Y-90 1-20GBQ Y90THERA
Gross
$125,998
J9229
$37,878
INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN
Gross
$124,046
J9229
$37,878
INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN
Gross
$124,046
C1787
$35,331
KT PULSE GEN 16 WAVEWRITER ALP M365SC12160
Gross
$115,706
C1787
$35,331
KT PULSE GEN 16 WAVEWRITER ALP M365SC12160
Gross
$115,706
77371
$35,005
HC SRS CMPL MS GAMMA KNIFE TMT
Gross
$114,636
77371
$35,005
HC SRS CMPL MS GAMMA KNIFE TMT
Gross
$114,636
J9350
$34,985
MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION
Gross
$114,570
J9350
$34,985
MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION
Gross
$114,570
C1822
$34,681
IPG W/KIT NIPG1500
Gross
$113,576
C1822
$34,681
IPG W/KIT NIPG1500
Gross
$113,576
L8614
$33,941
IMP COCHLEAR MODEL CI624 O P1431676
Gross
$111,154
L8614
$33,941
IMP COCHLEAR MODEL CI624 O P1431676
Gross
$111,154
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J0225 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $744,578 | $227,361 | $320,169 | $670,120 | 6 |
| J0225 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $744,578 | $227,361 | $320,169 | $670,120 | 5 |
| J1303 | RAVULIZUMAB-CWVZ 10 MG/ML INTRAVENOUS SOLUTION | $399,514 | $121,994 | $171,791 | $359,563 | 6 |
| J1303 | RAVULIZUMAB-CWVZ 10 MG/ML INTRAVENOUS SOLUTION | $399,514 | $121,994 | $221 | $359,563 | 27 |
| 90378 | PALIVIZUMAB 100 MG/ML INTRAMUSCULAR SOLUTION | $293,083 | $89,494 | $126,026 | $263,774 | 6 |
| 90378 | PALIVIZUMAB 100 MG/ML INTRAMUSCULAR SOLUTION | $293,083 | $89,494 | $340 | $263,774 | 28 |
| J0285 | AMPHOTERICIN B 0.1 MG/ML IV SYRINGE (NEONATE) | $290,074 | $88,576 | $124,732 | $261,067 | 6 |
| J0285 | AMPHOTERICIN B 0.1 MG/ML IV SYRINGE (NEONATE) | $290,074 | $88,576 | $124,732 | $261,067 | 5 |
| C1877 | THRAFLX HBRD ANTFLO 30X40X150A THA3040X150A | $248,448 | $75,865 | $106,832 | $223,603 | 5 |
| C1877 | THRAFLX HBRD ANTFLO 30X40X150A THA3040X150A | $248,448 | $75,865 | $106,832 | $223,603 | 5 |
| C1882 | ACTICOR 7 HF-T 429523 | $187,374 | $57,216 | $80,571 | $168,637 | 5 |
| C1882 | ACTICOR 7 HF-T 429523 | $187,374 | $57,216 | $80,571 | $168,637 | 5 |
| J2020 | LINEZOLID 2 MG/ML IV SYRINGE (NEONATE) | $176,905 | $54,019 | $76,069 | $159,215 | 6 |
| J2020 | LINEZOLID 2 MG/ML IV SYRINGE (NEONATE) | $176,905 | $54,019 | $175 | $159,215 | 6 |
| C1605 | PACER SYS AVEIR DUAL CHAMBER DR-SYSTEM-AVEIR | $170,364 | $52,022 | $73,257 | $153,328 | 5 |
| C1605 | PACER SYS AVEIR DUAL CHAMBER DR-SYSTEM-AVEIR | $170,364 | $52,022 | $73,257 | $153,328 | 5 |
| C1824 | OPTIMIZER SMART IPG 10-B411-3-XX | $163,266 | $49,854 | $70,204 | $146,939 | 5 |
| C1824 | OPTIMIZER SMART IPG 10-B411-3-XX | $163,266 | $49,854 | $70,204 | $146,939 | 5 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $162,690 | $49,678 | $69,957 | $146,421 | 6 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $162,690 | $49,678 | $69,957 | $146,421 | 5 |
| C1820 | KT IMP VERCISE GEVIA GENRTR M365DB1200S0 | $156,167 | $47,686 | $67,152 | $140,550 | 5 |
| C1820 | KT IMP VERCISE GEVIA GENRTR M365DB1200S0 | $156,167 | $47,686 | $67,152 | $140,550 | 5 |
| C1826 | NEUROSTIMULATOR RECHRG 977119 | $156,167 | $47,686 | $67,152 | $140,550 | 5 |
| C1826 | NEUROSTIMULATOR RECHRG 977119 | $156,167 | $47,686 | $67,152 | $140,550 | 5 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $155,647 | $47,528 | $66,928 | $140,082 | 6 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $155,647 | $47,528 | $13,243 | $140,082 | 28 |
| C1767 | DRG IPG PROCLAIM W/CONTROLLER 3664CTRLSYSXX | $152,937 | $46,700 | $65,763 | $137,643 | 5 |
| C1767 | DRG IPG PROCLAIM W/CONTROLLER 3664CTRLSYSXX | $152,937 | $46,700 | $65,763 | $137,643 | 5 |
| C2624 | SYS DEL PA SENS CARDIOMEMS CM2000 | $149,069 | $45,519 | $64,099 | $134,162 | 5 |
| C2624 | SYS DEL PA SENS CARDIOMEMS CM2000 | $149,069 | $45,519 | $64,099 | $134,162 | 5 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $146,973 | $44,879 | $63,198 | $132,275 | 6 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $146,973 | $44,879 | $172 | $132,275 | 28 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $146,606 | $44,767 | $63,041 | $131,945 | 6 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $146,606 | $44,767 | $63,041 | $131,945 | 5 |
| J0222 | PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION | $141,054 | $43,072 | $60,653 | $126,949 | 6 |
| J0222 | PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION | $141,054 | $43,072 | $98.83 | $126,949 | 27 |
| C2616 | THERASPHERE Y-90 1-20GBQ Y90THERA | $125,998 | $38,474 | $54,179 | $113,399 | 5 |
| C2616 | THERASPHERE Y-90 1-20GBQ Y90THERA | $125,998 | $38,474 | $19,462 | $113,399 | 28 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $124,046 | $37,878 | $53,340 | $111,641 | 6 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $124,046 | $37,878 | $2,580 | $111,641 | 27 |
| C1787 | KT PULSE GEN 16 WAVEWRITER ALP M365SC12160 | $115,706 | $35,331 | $49,753 | $104,135 | 5 |
| C1787 | KT PULSE GEN 16 WAVEWRITER ALP M365SC12160 | $115,706 | $35,331 | $49,753 | $104,135 | 5 |
| 77371 | HC SRS CMPL MS GAMMA KNIFE TMT | $114,636 | $35,005 | $49,294 | $103,173 | 4 |
| 77371 | HC SRS CMPL MS GAMMA KNIFE TMT | $114,636 | $35,005 | $8,509 | $103,173 | 28 |
| J9350 | MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION | $114,570 | $34,985 | $49,265 | $103,113 | 6 |
| J9350 | MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION | $114,570 | $34,985 | $49,265 | $103,113 | 5 |
| C1822 | IPG W/KIT NIPG1500 | $113,576 | $34,681 | $48,838 | $102,218 | 5 |
| C1822 | IPG W/KIT NIPG1500 | $113,576 | $34,681 | $48,838 | $102,218 | 5 |
| L8614 | IMP COCHLEAR MODEL CI624 O P1431676 | $111,154 | $33,941 | $47,796 | $100,039 | 5 |
| L8614 | IMP COCHLEAR MODEL CI624 O P1431676 | $111,154 | $33,941 | $47,796 | $100,039 | 5 |
Showing top 50 of 15,088 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.